Krishnan A, Sims OT, Surapaneni PK, Woreta TA, Alqahtani SA (2023) Risk of adverse cardiovascular outcomes among persons living with HIV and nonalcoholic fatty liver disease: a multicenter matched cohort study
While the FDA recently approved the first generic version of Victoza , or liraglutidea first-generation GLP-1 that has been on the FDA's shortage list since 2023demand for the once-daily injection has waned as patients move to more effective once-weekly treatments like Ozempic and Mounjaro
And platforms that demonstrate measurable improvements in adherence will find payers not only willing but eager to partner
Sourcing Tesamorelin and Ipamorelin as individual compounds provides flexibility but increases per-month cost by 1525% due to purchasing two separate products
The elusive roles of bacterial glutathione S-transferases: new lessons from genomes
We recommend it to protect against harmful free radicals and brighten the skin overall